Medicare Prescription Drug Coverage obligations in New Jersey

What the 93.770–New Jersey join is

CFDA 93.770 is titled MEDICARE PRESCRIPTION DRUG COVERAGE. Crossed with New Jersey place of performance, obligations sum to $6,261,886,953.22 on 152 awards. The national 93.770 hub includes other states. New Jersey’s spending hub includes other programs. Only this intersection is reported here. $6,261,886,953.22 is an obligation aggregate from USAspending.gov, not an outlay and not a count of Part D enrollees in Newark, Trenton, or the shore counties.

152 awards is a concentrated health-insurance book: fewer rows than many SSA cells, larger mean per record. The join does not name plans, pharmacies, or CMS contractors. Packet facts stop at $6,261,886,953.22, 152 awards, NJ, and 93.770.

93.770 is not Medicare hospital insurance or CHIP

Medicare hospital and medical insurance catalogs and the Children’s Health Insurance Program (CFDA 93.767) are different HHS lines. Mixing those dollars into $6,261,886,953.22 would invent a broader health total than this cell contains. Medicaid uses other numbers still. Facts available: New Jersey, CFDA 93.770, $6,261,886,953.22, 152 awards. Formulary lists and premium counts are not in the facts.

The catalog title names Medicare Prescription Drug Coverage, not a ranking of pharmacy need. Dividing $6,261,886,953.22 by 152 yields about $41.20 million per award—a record-level ratio, not a typical monthly Part D premium. Unique recipients are unpublished. 152 is not a count of pharmacies.

New Jersey geography on the Part D tag

NJ is the place-of-performance code. A Part D award can still appear as records tagged to Trenton, Newark, or another in-state address. Awards coded to New York, Pennsylvania, or Delaware stay outside $6,261,886,953.22 even when an enrollee lives in a cross-border metro. The code does not convert $6.26 billion into a county map.

New Jersey federal spending is the all-program parent. 93.770 is one row on New Jersey programs. $6.26 billion is not the state’s complete federal footprint. Open Medicare Prescription Drug Coverage in New Jersey for the filtered table, CFDA 93.770 for 93.770 without a New Jersey filter, and All spending ties for other pairs. Do not add those parents into $6,261,886,953.22.

Reading 152 awards under $6.26 billion

$6,261,886,953.22 ÷ 152 is about $41.20 million per award. That average is a ratio of two packet facts, not a typical prescription cost and not a median. Net obligations can include downward modifications; the total shown is the aggregate in the facts. Treat 152 as a record count, not as 152 finished drug plans.

USAspending obligations can be positive new awards or net of downward modifications; $6,261,886,953.22 is the net total supplied in the facts. Without a transaction register, you cannot see how many of the 152 rows are continuations, corrections, or plan-year instruments. Later ingests can restate $6,261,886,953.22 without changing the join key of 93.770 and NJ.

What the Part D–New Jersey pair does not prove

A large 93.770 total tagged to New Jersey does not measure whether prescriptions were filled, and it does not equal services delivered. FEC donations do not fund this USAspending cell. Correlation is not causation. The headline remains $6,261,886,953.22 on 152 awards for Medicare Prescription Drug Coverage in New Jersey.

Keep both sides of the join: Medicare Prescription Drug Coverage and New Jersey, obligations only. Do not annualize $6,261,886,953.22 without a year field—this packet publishes none. Do not treat 152 as an enrollee census. Quote USAspending.gov and the overlay path rather than a pharmacy story.

Using the 93.770–New Jersey overlay

The overlay target is the New Jersey × CFDA 93.770 table. Open Medicare Prescription Drug Coverage in New Jersey when you want the same $6,261,886,953.22 / 152-award cell in the site’s data chrome. CFDA 93.770 drops the New Jersey filter. New Jersey federal spending drops the CFDA filter. New Jersey programs lists other catalogs beside 93.770. All spending ties indexes other pairs.

This page exists because two tables meet: a CFDA program and a place-of-performance state. It does not exist to argue that New Jersey won or lost federal money, that donations paid for the awards, or that obligations equal cash. The pair is 93.770 plus NJ. Obligations of $6,261,886,953.22 are not outlays.

Questions

How much Medicare Prescription Drug Coverage is obligated in New Jersey?

USAspending records $6,261,886,953.22 in CFDA 93.770 obligations with New Jersey place of performance on 152 awards. That is the pair total, not an outlay and not CHIP. Keep Medicare Prescription Drug Coverage and New Jersey together when citing $6,261,886,953.22.

Are 152 awards 152 Part D plans?

152 is an award-record count, not a plan census. The mean is about $41.20 million per award, a ratio, not a typical premium. Unique recipients are unpublished. Original filings remain on USAspending.gov.

Is this New Jersey’s total Medicare spending?

No. This join is CFDA 93.770 only. Hospital insurance, medical insurance, and CHIP catalogs appear on separate New Jersey program pages. Nationwide 93.770 is not limited to New Jersey. Obligations of $6,261,886,953.22 are not outlays.

Where is the live 93.770–New Jersey table?

The overlay is Medicare Prescription Drug Coverage in New Jersey. CFDA 93.770 drops the state filter. New Jersey federal spending and New Jersey programs are the state parents. All spending ties indexes other pairs. Original filings remain on USAspending.gov.